CJC-1295 W/ DAC 5mg

Description

CJC-1295 w/ DAC | 5mg | Long-Acting GHRH Analog Peptide

Description

CJC-1295 w/ DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) engineered for extended activity in laboratory research models. This 30-amino-acid peptide incorporates a Drug Affinity Complex (DAC) modification designed to enhance stability and prolong functional activity in experimental systems.

In controlled in vitro research, CJC-1295 w/ DAC is commonly studied for its interaction with GHRH receptor pathways associated with anterior pituitary signaling and growth hormone release dynamics. The DAC modification enables albumin binding, which supports longer persistence in experimental environments compared with shorter-acting GHRH analogs.

Researchers frequently utilize this compound in endocrine signaling studies involving sustained growth hormone release profiles, IGF-1 pathway modeling, and receptor-mediated hormonal regulation. Its extended-duration characteristics make it especially useful for laboratory investigations comparing pulsatile versus prolonged endocrine signaling responses.

This vial contains 5mg of lyophilized CJC-1295 w/ DAC peptide intended strictly for controlled in vitro laboratory research applications.

Specifications

• Unit Size: 5mg (lyophilized powder, single vial)
• Amino Acid Length: 30 amino acids
• Molecular Formula: C165H269N47O46
• Molecular Weight: ~3367.95 g/mol
• Form: Lyophilized peptide powder
• Solubility: Soluble in sterile water or compatible aqueous buffers according to laboratory protocols
• Storage: Store lyophilized material at 2–8 °C in a dry, dark environment; refrigerate reconstituted solutions at 2–8 °C according to laboratory protocol

Research Applications

Sustained Growth Hormone Release Research

CJC-1295 w/ DAC is widely used in laboratory studies examining prolonged growth hormone release profiles. Researchers investigate how extended receptor engagement influences endocrine signaling duration compared with shorter-acting releasing hormone analogs.

GH/IGF-1 Axis Regulation Research

This peptide is frequently studied in experimental systems focused on growth hormone and insulin-like growth factor signaling relationships. These models help characterize downstream endocrine responses and broader hormonal regulatory mechanisms.

Pituitary Receptor Signaling Research

Laboratory models commonly use CJC-1295 w/ DAC to investigate GHRH receptor activation and intracellular signaling pathways in anterior pituitary systems. These studies support research into receptor binding, signal transduction, and hormonal secretion dynamics.

Long-Acting Peptide Pharmacokinetics Research

The DAC modification makes this compound useful for in vitro investigations involving peptide stability, albumin-associated persistence, and long-acting receptor engagement characteristics. Researchers use these models to study how structural modifications affect peptide duration and functional activity.

Endocrine Signaling Pattern Research

CJC-1295 w/ DAC is also applied in studies comparing pulsatile versus sustained endocrine stimulation models. These investigations help researchers evaluate how prolonged hormone-releasing signals alter downstream pathway behavior in controlled experimental settings.

Intended Use

Intended strictly for in vitro laboratory research use.

Legal Disclaimer

This product has not been evaluated by the U.S. Food and Drug Administration. No claims are made regarding the treatment, diagnosis, cure, or prevention of any disease. All information provided is intended strictly for scientific and educational purposes only.

Terms of Sale

All sales are final